High Density of CD16+ Tumor-Infiltrating Immune Cells in Recurrent Ovarian Cancer Is Associated with Enhanced Responsiveness to Chemotherapy and Prolonged Overall Survival

SIMPLE SUMMARY: The late—and in most cases at an advanced stage—diagnosis of patients with ovarian cancer (OC) and the high recurrence rate make this malignant disease the most lethal among gynecological cancers. With a mortality-to-incidence ratio of 0.74, OC is a tumor with the fifth most frequent...

Descripción completa

Detalles Bibliográficos
Autores principales: Lalos, Alexandros, Neri, Ornella, Ercan, Caner, Wilhelm, Alexander, Staubli, Sebastian, Posabella, Alberto, Weixler, Benjamin, Terracciano, Luigi, Piscuoglio, Salvatore, Stadlmann, Sylvia, Spagnoli, Giulio C., Droeser, Raoul A., Singer, Gad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616362/
https://www.ncbi.nlm.nih.gov/pubmed/34830938
http://dx.doi.org/10.3390/cancers13225783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616362/
https://www.ncbi.nlm.nih.gov/pubmed/34830938
http://dx.doi.org/10.3390/cancers13225783

Ejemplares similares